These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow. McMullan DM; Permut LC; Jones TK; Johnston TA; Rubio AE J Thorac Cardiovasc Surg; 2014 Jan; 147(1):397-401. PubMed ID: 24071469 [TBL] [Abstract][Full Text] [Related]
7. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease. Høst A; Halken S; Andersen PE Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113 [TBL] [Abstract][Full Text] [Related]
8. Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts. Sivakumar K; Shivaprakasha K; Rao SG; Kumar RK Indian Heart J; 2001; 53(1):66-70. PubMed ID: 11456144 [TBL] [Abstract][Full Text] [Related]
9. "Reverse Blalock-Taussig shunt": application in single ventricle hybrid palliation. Baba K; Honjo O; Chaturvedi R; Lee KJ; Van Arsdell G; Caldarone CA; Benson LN J Thorac Cardiovasc Surg; 2013 Aug; 146(2):352-7. PubMed ID: 23228402 [TBL] [Abstract][Full Text] [Related]
10. A five-year clinical experience with 112 Blalock-Taussig shunts. Gold JP; Violaris K; Engle MA; Klein AA; Ehlers KH; Lang SJ; Levin AR; Moran F; O'Loughlin JE; Snyder MS J Card Surg; 1993 Jan; 8(1):9-17. PubMed ID: 8422496 [TBL] [Abstract][Full Text] [Related]
11. The Blalock-Taussig shunt in infants: standard versus modified. Ullom RL; Sade RM; Crawford FA; Ross BA; Spinale F Ann Thorac Surg; 1987 Nov; 44(5):539-43. PubMed ID: 3675059 [TBL] [Abstract][Full Text] [Related]
12. Hyperostosis: an under-recognized complication of prostaglandin infusion. Abdelaziz M; John CM Acta Paediatr; 2013 May; 102(5):e192. PubMed ID: 23414095 [No Abstract] [Full Text] [Related]
13. Clinical results of combined palliative procedures for cyanotic congenital heart defects with intractable hypoplasia of pulmonary arteries. Fan XM; Zhu YB; Su JW; Zhang J; Li ZQ; Xu YQ; Li XF; Liu YL Chin Med J (Engl); 2013; 126(9):1678-82. PubMed ID: 23652050 [TBL] [Abstract][Full Text] [Related]
14. Blalock-Taussig shunts and modified Blalock-Taussig shunts. Sanchez HE; Vosloo S S Afr Med J; 1985 Feb; 67(5):168-70. PubMed ID: 3983755 [TBL] [Abstract][Full Text] [Related]
15. Systemic-pulmonary shunts in infants and children. Early and late results. Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171 [TBL] [Abstract][Full Text] [Related]
16. Interventions Involving the Use of Covered Coronary Artery Stents for Pseudoaneurysms of Blalock-Taussig Shunts. Baspinar O; Sahin DA; Sulu A; Gokaslan G World J Pediatr Congenit Heart Surg; 2016 Jul; 7(4):494-7. PubMed ID: 26852366 [TBL] [Abstract][Full Text] [Related]
17. The use of prostaglandin E1 and Blalock-Taussig shunts in neonates with cyanotic congenital heart disease. Browdie DA; Norberg W; Agnew R; Altenburg B; Ignacio R; Hamilton C Ann Thorac Surg; 1979 Jun; 27(6):508-13. PubMed ID: 454028 [TBL] [Abstract][Full Text] [Related]